While the two currently available COVID-19 vaccines in the U.S. are both based on mRNA designs — which actually are experimental gene therapies, not true vaccines — the Oxford-AstraZeneca vaccine is different.
The differences are what The Corbett Report focuses on with Whitney Webb, a writer and researcher who covers intelligence, tech, surveillance and civil liberties. In this YouTube presentation, Webb reveals that not only is the Oxford-AstraZeneca vaccine different from Moderna’s and Pfizer’s, but its developers have ties to the U.K. Eugenics Movement.
Before she gets into how certain high-profile people and organizations around the world are tied to the Oxford vaccine, Webb points out it doesn’t require the deep-freeze cold storage the others do, which makes it ideal for developing countries such as those in Africa.
The nuances of the Oxford vaccine’s development are the most curious, though, as it has huge ties and backing from organizations such as the Wellcome Trust — which is also the archivist for the Eugenics Society — GAVI, the Jenner Institute and even Google. Also, while they claim that this vaccine is less profitable than Moderna’s and Pfizer’s, the makers’ plans are to make huge profits from it once the pandemic is over.
And the eugenics of it? Once Webb reveals that the Wellcome Trust “recently funded a paper that essentially argued that as long as eugenics isn’t coercive, it’s acceptable policy,” all kinds of questions arise, beginning with: Why is this particularly vaccine “being marketed specifically to developing countries?”
SOURCE: The Corbett Report February 24, 2021